Bortezomib Aspire Pharma (Malta)

Bortezomib is a medication used for certain types of cancer treatment. It is administered intravenously and is manufactured by Aspire Pharma (Malta) Limited.

Bortezomib is primarily used in the treatment of multiple myeloma and mantle cell lymphoma. This medication works by targeting and inhibiting proteins in cancer cells, which can help slow or stop their growth. Patients often wonder, 'What is Bortezomib used for?' and it is typically prescribed for these specific cancer types.

Common effects of Bortezomib may include fatigue, nausea, and peripheral neuropathy. Some patients also experience diarrhea or constipation. These effects can vary in severity and may differ from person to person.

Bortezomib should be handled with care and administered under medical supervision. It is important to follow all safety guidelines provided by healthcare professionals. Patients with pre-existing conditions should discuss their medical history with their doctor before starting treatment.

Bortezomib may interact with other medications, including those that affect liver enzymes. It is advisable to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain supplements may also interact with Bortezomib.